1)  AS1949490, an inhibitor of 5'-lipid phosphatase SHIP2, promotes protein kinase C-dependent stabilization of brain-derived neurotrophic factor mRNA in cultured cortical neurons.
Tsuneki H, Yoshida H, Okamoto K, Yamaguchi M, Endo K, Nakano A, Tsuda M, Toyooka N, Wada T, Sasaoka T.
Eur J Pharmacol. 851: 69-79, 2019.

2)  Chronotherapeutic effect of orexin antagonists on glucose metabolism in diabetic mice.
Kon K, Tsuneki H, Ito H, Takemura Y, Sato K, Yamazaki M, Ishii Y, Sasahara M, Rudich A, Maeda T, Wada T, Sasaoka T.
J Endocrinol. 243: 59-72., 2019.

3)  N-acetylaspartate availability is essential for juvenile survival on fat-free diet and determines metabolic health.
Hofer DC, Zirkovits G, Pelzmann HJ, Huber K, Pessentheiner AR, Xia W, Uno K, Miyazaki T, Kon K, Tsuneki H, Pendl T, Al Zoughbi W, Madreiter-Sokolowski CT, Trausinger G, Abdellatif M, Schoiswohl G, Schreiber R, Eisenberg T, Magnes C, Sedej S, Eckhardt M, Sasahara M, Sasaoka T, Nitta A, Hoefler G, Graier WF, Kratky D, Auwerx J, Bogner-Strauss JG.
FASEB J. 33: 13808-13824., 2019.